All articles by Refna Tharayil
Refna Tharayil
Bluenote secures $10m to enhance AI capabilities in life sciences
The company’s AI platform streamlines workflows for life sciences, supporting tasks like regulatory filings, technical reports, and SOPs
Zai Lab and Innoviva get Chinese approval for Xacduro in HABP/VABP
The approval was based on the positive results from Phase 3 ATTACK trial in which Xacduro proved its statistical non-inferiority to colistin regarding the primary endpoint of 28-day all-cause mortality